StonvexLoading…
StonvexStonvexStonvexCore line items from DLTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-02-01 | Q4 2025 2025-11-02 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|
Revenue | $565.18M | $349.29M | $234.42M | $102.70M |
Operating Income | $-10.16M | $-18.78M | $-9.95M | $-12.35M |
Net Income | $-16.39M | $-24.13M | $-14.03M | $-15.29M |
EPS (Diluted) | $-0.47 | $-0.71 | $-0.41 | $-0.45 |
Total Assets | $402.61M | $468.01M | $433.80M | $463.70M |
Total Liabilities | $236.49M | $310.32M | $266.74M | $298.81M |
Cash & Equivalents | $16.34M | $8.17M | $5.74M | $8.58M |
Free Cash Flow OCF − CapEx | $16.57M | $-36.95M | $-28.01M | $-57.80M |
Shares Outstanding | 34.62M | 34.23M | 34.08M | 33.71M |